The single study provided does not actually investigate Boswellia or its use for asthma support — it examined ARTIVeda, an artemisinin-based supplement derived from Artemisia, as a treatment for mild-to-moderate COVID-19. As a result, no research evidence on Boswellia for asthma can be synthesized from the sources supplied. Readers interested in the evidence base for Boswellia and respiratory conditions such as asthma are encouraged to consult published literature specifically examining Boswellia serrata or its active compounds, such as boswellic acids, in that context.
Citations from PubMed and preprint sources. Match score (0-100) reflects automated search ranking, not clinical appraisal.
| Title | Type | Year | Direction | Match |
|---|---|---|---|---|
| Targeting TGF-β pathway with COVID-19 Drug Candidate ARTIVeda/PulmoHeal Accel... | Other | 2021 | Neutral | 90 |